Photo: KidStock/Blend Images/GettyImages
Baby monitoring company Owlet announced that its Dream Sight video monitoring device has earned the SGS Cybersecurity Mark, a global certification that recognizes the highest standards in international cybersecurity and privacy.
According to Owlet, Dream Sight was tested by Brightsight, an SGS company involved in cybersecurity evaluations.
Additionally, the SGS certification determines that Dream Sight meets the requirements of the European Union’s Radio Equipment Directive.
Dream Sight features 2K HD (a display resolution of 2,000 pixels horizontally) streaming with night vision, motion and sound detection, two-way audio, and temperature and humidity tracking.
Dream Sight's video and audio monitoring system can function independently or integrate with Owlet's FDA-cleared Dream Sock, an over-the-counter smart baby monitor that provides live, clinically validated information on a baby’s pulse rate, oxygen level, and sleep and overall wellness trends.
"As smart home devices become an essential part of parenting, cybersecurity is not optional," Jonathan Harris, president and CEO of Owlet, said in a statement.
THE LARGER TREND
In October, Owlet received approval from India’s Central Drugs Standard Control Organization (CDSCO) to distribute its wearable smart baby monitor.
The company said the monitor is the first among its suite of infant monitoring solutions to be approved for distribution in India.
In September, Harris sat down with MobiHealthNews to talk about the company's baby monitoring offerings.
Regarding Owlet's development of AI features, Harris said, "Because we have the world's largest pediatric health platform, we are able to take our AI and apply that to drive more insights and innovations and tips and tricks for families to help them on their journey."
The company's stock is currently trading at $8.89 per share.
In August, Owlet reported a 25.9% increase in revenue to $26.1 million for the second quarter of 2025, up from $20.7 million in the same period last year, which the company attributed to increased sales of its FDA-cleared and CE marked Dream Sock and baby sleep monitoring system Dream Duo.
The company reported a net loss of $37.6 million, including a $34.8 million non-cash, mark-to-market common stock warrant liability adjustment.
Owlet also reported a net loss in the same period last year of $1.1 million.
Adjusted EBITDA was $0.3 million in the second quarter of this year, up $0.2 million compared to Q2 2024.
The company altered its financial forecast, claiming that it expected revenue to range from $97 million to $100 million, with 24% to 28% year-over-year growth.
Gross margins were expected to range from 46% to 50%, which the company says includes the impact of new expected tariff costs.
The company said it expects to be adjusted EBITDA profitable for the full year 2025.
Owlet also reported that it finalized a deal with most holders of its Series A and Series B warrants to convert its warrants into common stock.
Other companies in the baby sleep monitoring space include Royal Philips, which in 2024 launched the Philips Avent Premium Connected Baby Monitor, which comes with the company's proprietary SenseIQ sleep, breathing-tracking and cry-detection, and translation technologies.
A baby unit camera, parent unit and the Philips Avent Baby Monitor+ mobile app give parents the ability to view the baby, while SenseIQ tracking technology evaluates millions of pixels every second and translates the chest motions of a baby's breathing into sleep status and breathing rate updates. The system does not require a wearable device.
